Patents by Inventor Satoshi Hirohata

Satoshi Hirohata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8865669
    Abstract: The invention relates to a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1, or a nucleotide sequence the same or substantially the same as a partial nucleotide sequence thereof containing at least one HRE consensus sequence, which transiently has a transcription promoting activity in a vascular endothelial cell-specific manner in a hypoxic state, or a vector containing a promoter containing the DNA, and the like. The prophylaxis and/or treatment, as well as diagnosis, of acute ischemic diseases are enabled by connecting a prophylactic and/or therapeutic gene or a reporter gene to the downstream of the vector and administering same to mammals.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: October 21, 2014
    Assignee: National University Corporation Okayama University
    Inventors: Satoshi Hirohata, Yoshifumi Ninomiya, Shozo Kusachi, Faruk Hatipoglu Omer
  • Publication number: 20110023155
    Abstract: The invention relates to a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1, or a nucleotide sequence the same or substantially the same as a partial nucleotide sequence thereof containing at least one HRE consensus sequence, which transiently has a transcription promoting activity in a vascular endothelial cell-specific manner in a hypoxic state, or a vector containing a promoter containing the DNA, and the like. The prophylaxis and/or treatment, as well as diagnosis, of acute ischemic diseases are enabled by connecting a prophylactic and/or therapeutic gene or a reporter gene to the downstream of the vector and administering same to mammals.
    Type: Application
    Filed: February 4, 2009
    Publication date: January 27, 2011
    Applicant: NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
    Inventors: Satoshi Hirohata, Yoshifumi Ninomiya, Shozo Kusachi, Faruk Hatipoglu Omer
  • Publication number: 20030077811
    Abstract: The present invention is directed to ADAMTS3 and the corresponding protein ADAMTS-3 as well as variants, homologs, and equivalents, and their use in procollagen processing.
    Type: Application
    Filed: June 6, 2002
    Publication date: April 24, 2003
    Inventors: Suneel S. Apte, Satoshi Hirohata, David R. Eyre, Russell J. Fernandes
  • Publication number: 20020110894
    Abstract: Isolated mammalian proteins having disintegrin-like and metalloprotease domains with thrombospondin type I motifs, i.e., ADAMTS proteins, are provided. The proteins are ADAMTS-5, ADAMTS-6, ADAMTS-7, ADAMTS-8, ADAMTS-9 and ADAMTS-10, collectively referred to as 5 “ADAMTS-N”. The present invention also provides isolated polynucleotides which encode an ADAMTS-N protein or a variant thereof, polynucleotide sequences complementary to such polynucleotides, vectors containing such polynucleotides, and host cells transformed or transfected with such vectors. The present invention also relates to antibodies which are immunospecific for one or more of the ADAMTS-N proteins. The present invention also relates to a protein referred to hereinafter as ADAMTS-R1 (ADAM-TS Related protein-1) and the polynucleotides which encode such protein.
    Type: Application
    Filed: July 30, 2001
    Publication date: August 15, 2002
    Inventors: Suneel S. Apte, Tiina L. Hurskainen, Satoshi Hirohata
  • Patent number: 6391610
    Abstract: Isolated mammalian proteins having disintegrin-like and metalloprotease domains with thrombospondin type I motifs, i.e., ADAMTS proteins, are provided. The proteins are ADAMTS-5, ADAMTS-6, ADAMTS-7, ADAMTS-8, ADAMTS-9 and ADAMTS-10, collectively referred to as “ADAMTS-N”. The present invention also provides isolated polynucleotides which encode an ADAMTS-N protein or a variant thereof, polynucleotide sequences complementary to such polynucleotides, vectors containing such polynucleotides, and host cells transformed or transfected with such vectors. The present invention also relates to antibodies which are immunospecific for one or more of the ADAMTS-N proteins. The present invention also relates to a protein referred to hereinafter as ADAMTS-R1 (ADAM-TS Related protein-1) and the polynucleotides which encode such protein.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: May 21, 2002
    Assignee: The Cleveland Clinic Foundation
    Inventors: Suneel S. Apte, Tiina L. Hurskainen, Satoshi Hirohata
  • Patent number: 5583543
    Abstract: A pen input processing apparatus in accordance with the present invention has a text editing section for displaying on a screen a window through which a character is handwritten only by handwriting on the screen a line drawing indicative of inputting of character by handwriting. The text editing section has a function wherein the name of gesture command corresponding to a line drawing and the character to be edited are displayed by the screen when each line drawing is handwritten with respect to the screen. The pen input processing apparatus has a gesture command judging section for recognizing the gesture command in accordance with a trace coordinate of the line drawing. When the gesture command is recognized and specified, the recognition of the gesture command is informed by a sound. Only one line drawing is assigned to the same editing instructions for one character and a plurality of characters as editing objects.
    Type: Grant
    Filed: November 1, 1993
    Date of Patent: December 10, 1996
    Assignee: Sharp Kabushiki Kaisha
    Inventors: Masamitsu Takahashi, Yukihiro Shibata, Aki Miake, Hiroshi Okuno, Hiroshi Nishida, Yutaka Nakamura, Hiroyuki Shigematsu, Satoshi Hirohata